COVID-19: IgG seroconversion under intensive glucocorticoid treatment in a high-risk patient with minimal change disease

In this case report we present a rare case of a patient with multiple risk factors for severe coronavirus disease (COVID 19) in whom intensive glucocorticoid treatment due to incipient nephrotic syndrome coincided with SARS-CoV‑2 infection. Despite this high baseline risk profile and the use of gluc...

Descripción completa

Detalles Bibliográficos
Autores principales: Eder, Michael, Strassl, Robert, Kläger, Johannes, Aigner, Christof, Thalhammer, Florian, Kikić, Željko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722244/
https://www.ncbi.nlm.nih.gov/pubmed/33289854
http://dx.doi.org/10.1007/s00508-020-01776-w
_version_ 1783620116693385216
author Eder, Michael
Strassl, Robert
Kläger, Johannes
Aigner, Christof
Thalhammer, Florian
Kikić, Željko
author_facet Eder, Michael
Strassl, Robert
Kläger, Johannes
Aigner, Christof
Thalhammer, Florian
Kikić, Željko
author_sort Eder, Michael
collection PubMed
description In this case report we present a rare case of a patient with multiple risk factors for severe coronavirus disease (COVID 19) in whom intensive glucocorticoid treatment due to incipient nephrotic syndrome coincided with SARS-CoV‑2 infection. Despite this high baseline risk profile and the use of glucocorticoids the patient developed only mild disease including IgG SARS-CoV‑2 seroconversion.
format Online
Article
Text
id pubmed-7722244
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Vienna
record_format MEDLINE/PubMed
spelling pubmed-77222442020-12-08 COVID-19: IgG seroconversion under intensive glucocorticoid treatment in a high-risk patient with minimal change disease Eder, Michael Strassl, Robert Kläger, Johannes Aigner, Christof Thalhammer, Florian Kikić, Željko Wien Klin Wochenschr Case Report In this case report we present a rare case of a patient with multiple risk factors for severe coronavirus disease (COVID 19) in whom intensive glucocorticoid treatment due to incipient nephrotic syndrome coincided with SARS-CoV‑2 infection. Despite this high baseline risk profile and the use of glucocorticoids the patient developed only mild disease including IgG SARS-CoV‑2 seroconversion. Springer Vienna 2020-12-08 2021 /pmc/articles/PMC7722244/ /pubmed/33289854 http://dx.doi.org/10.1007/s00508-020-01776-w Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Case Report
Eder, Michael
Strassl, Robert
Kläger, Johannes
Aigner, Christof
Thalhammer, Florian
Kikić, Željko
COVID-19: IgG seroconversion under intensive glucocorticoid treatment in a high-risk patient with minimal change disease
title COVID-19: IgG seroconversion under intensive glucocorticoid treatment in a high-risk patient with minimal change disease
title_full COVID-19: IgG seroconversion under intensive glucocorticoid treatment in a high-risk patient with minimal change disease
title_fullStr COVID-19: IgG seroconversion under intensive glucocorticoid treatment in a high-risk patient with minimal change disease
title_full_unstemmed COVID-19: IgG seroconversion under intensive glucocorticoid treatment in a high-risk patient with minimal change disease
title_short COVID-19: IgG seroconversion under intensive glucocorticoid treatment in a high-risk patient with minimal change disease
title_sort covid-19: igg seroconversion under intensive glucocorticoid treatment in a high-risk patient with minimal change disease
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722244/
https://www.ncbi.nlm.nih.gov/pubmed/33289854
http://dx.doi.org/10.1007/s00508-020-01776-w
work_keys_str_mv AT edermichael covid19iggseroconversionunderintensiveglucocorticoidtreatmentinahighriskpatientwithminimalchangedisease
AT strasslrobert covid19iggseroconversionunderintensiveglucocorticoidtreatmentinahighriskpatientwithminimalchangedisease
AT klagerjohannes covid19iggseroconversionunderintensiveglucocorticoidtreatmentinahighriskpatientwithminimalchangedisease
AT aignerchristof covid19iggseroconversionunderintensiveglucocorticoidtreatmentinahighriskpatientwithminimalchangedisease
AT thalhammerflorian covid19iggseroconversionunderintensiveglucocorticoidtreatmentinahighriskpatientwithminimalchangedisease
AT kikiczeljko covid19iggseroconversionunderintensiveglucocorticoidtreatmentinahighriskpatientwithminimalchangedisease

Ejemplares similares